In This Section

13th AACR-JCA Joint Conference: From Cancer Discovery Science to Therapeutic Innovation

February 1-5, 2025
Hyatt Regency Maui
Maui, Hawaii

Abstract Submission Deadline: Thursday, November 14, 2024 1 p.m. ETSubmit an Abstract
Advance Registration Deadline: Friday, December 20, 2024Register Now
Hotel Reservation Deadline: Wednesday, January 1, 2025Reserve a Room

AACR Organizing Committee

Catherine J. Wu, Cochair, Dana-Farber Cancer Center, Boston, Massachusetts
Marcia C. Haigis, Harvard Medical School, Boston, Massachusetts
Andrew Futreal, MD Anderson Cancer Center, Houston, Texas
Nathaneal S. Gray, Stanford University, Stanford, California
Elizabeth A. Platz, Johns Hopkins University, Baltimore, Maryland
Benjamin Haibe-Kains, University of Toronto, Toronto, Ontario, Canada
Sheila A. Stewart, Washington University in St. Louis, St. Louis, Missouri
Jorge Reis-Filho, AstraZeneca, Gaithersburg, Massachusetts

JCA Organizing committee

Hiroyuki Mano, Cochair, National Cancer Center Japan, Tokyo, Japan
Hiroyoshi Nishikawa, National Cancer Center Japan, Tokyo, Japan
Akiko Takahashi, Japanese Foundation for Cancer Research, Tokyo, Japan
Nobuyuki Kakiuchi, Kyoto University, Kyoto, Japan
Yuki Kagoya, Keio University School of Medicine, Tokyo, Japan
Noriko Gotoh, Kanazawa University Cancer Research Institute, Ishikawa, Japan
Takashi Owa, Eisai Inc., Nutley, New Jersey
Ashok Venkitaraman, Cancer Science Institute of Singapore, Singapore

The American Association for Cancer Research (AACR) and Japanese Cancer Association (JCA) are proud to offer this 13th AACR-JCA Joint Conference. This meeting series has a long tradition of bringing together outstanding researchers from the United States, Japan, and around the world to share their findings and present the latest advances in basic, translational, and clinical cancer research. Formal and informal interactions as well as international collaborations are fostered through this unique forum. Just as its predecessors have done, this AACR-JCA Joint Conference will take a broad view of contemporary cancer research and will be of interest to basic, translational, and clinical investigators at all career levels.